Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use?
Dyspnea is a common and distressing symptom associated with multiple chronic illness and high levels of burden for individuals, their families and health care systems. The subjective nature dyspnea and a poor understanding of pathophysiological mechanisms challenge the clinician in developing manage...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier
2008
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/45269 |
| _version_ | 1848757235172245504 |
|---|---|
| author | Newton, Phillip Davidson, Patricia Macdonald, P. Ollerton, R. Krum, H. |
| author_facet | Newton, Phillip Davidson, Patricia Macdonald, P. Ollerton, R. Krum, H. |
| author_sort | Newton, Phillip |
| building | Curtin Institutional Repository |
| collection | Online Access |
| description | Dyspnea is a common and distressing symptom associated with multiple chronic illness and high levels of burden for individuals, their families and health care systems. The subjective nature dyspnea and a poor understanding of pathophysiological mechanisms challenge the clinician in developing management plans. Nebulized furosemide has been identified as a novel approach to dyspnea management. This review summarizes published studies, both clinical and experimental, reporting the use of nebulized furosemide. The search criteria yielded 42 articles published in the period 1988 to 2004. Although nebulized furosemide appeared to have a positive influence on dyspnea and physiological measurements, caution must be taken with the results primarily coming from small-scale clinical trials or observation trials. Despite the limitations of the studies reported, given the range of conditions reporting effectiveness of nebulized furosemide, further investigation of this potential novel treatment of dyspnea is warranted. |
| first_indexed | 2025-11-14T09:24:52Z |
| format | Journal Article |
| id | curtin-20.500.11937-45269 |
| institution | Curtin University Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-14T09:24:52Z |
| publishDate | 2008 |
| publisher | Elsevier |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | curtin-20.500.11937-452692019-02-19T05:35:12Z Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? Newton, Phillip Davidson, Patricia Macdonald, P. Ollerton, R. Krum, H. chronic disease inhalation drug administration acute disease dyspnea Furosemide Dyspnea is a common and distressing symptom associated with multiple chronic illness and high levels of burden for individuals, their families and health care systems. The subjective nature dyspnea and a poor understanding of pathophysiological mechanisms challenge the clinician in developing management plans. Nebulized furosemide has been identified as a novel approach to dyspnea management. This review summarizes published studies, both clinical and experimental, reporting the use of nebulized furosemide. The search criteria yielded 42 articles published in the period 1988 to 2004. Although nebulized furosemide appeared to have a positive influence on dyspnea and physiological measurements, caution must be taken with the results primarily coming from small-scale clinical trials or observation trials. Despite the limitations of the studies reported, given the range of conditions reporting effectiveness of nebulized furosemide, further investigation of this potential novel treatment of dyspnea is warranted. 2008 Journal Article http://hdl.handle.net/20.500.11937/45269 10.1016/j.jpainsymman.2007.10.017 Elsevier fulltext |
| spellingShingle | chronic disease inhalation drug administration acute disease dyspnea Furosemide Newton, Phillip Davidson, Patricia Macdonald, P. Ollerton, R. Krum, H. Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title | Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title_full | Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title_fullStr | Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title_full_unstemmed | Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title_short | Nebulized Furosemide for the Management of Dyspnea: Does the Evidence Support Its Use? |
| title_sort | nebulized furosemide for the management of dyspnea: does the evidence support its use? |
| topic | chronic disease inhalation drug administration acute disease dyspnea Furosemide |
| url | http://hdl.handle.net/20.500.11937/45269 |